Correlation Between Dynavax Technologies and Eledon Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Eledon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Eledon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dynavax Technologies and Eledon Pharmaceuticals, you can compare the effects of market volatilities on Dynavax Technologies and Eledon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Eledon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Eledon Pharmaceuticals.

Diversification Opportunities for Dynavax Technologies and Eledon Pharmaceuticals

0.81

Correlation Coefficient

Dynavax Technologies  Eledon Pharmaceuticals

Very poor diversification

The 3 months correlation between Dynavax and Eledon is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Eledon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eledon Pharmaceuticals and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Eledon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eledon Pharmaceuticals has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Eledon Pharmaceuticals go up and down completely randomly.

Pair Corralation between Dynavax Technologies and Eledon Pharmaceuticals

Given the investment horizon of 90 days Dynavax Technologies is expected to generate 0.18 times more return on investment than Eledon Pharmaceuticals. However, Dynavax Technologies is 5.56 times less risky than Eledon Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Eledon Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest  1,279  in Dynavax Technologies on October 4, 2024 and sell it today you would lose (2.00) from holding Dynavax Technologies or give up 0.16% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Dynavax Technologies  vs.  Eledon Pharmaceuticals

Dynavax Technologies

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Eledon Pharmaceuticals

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dynavax Technologies and Eledon Pharmaceuticals

The main advantage of trading using opposite Dynavax Technologies and Eledon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Eledon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will offset losses from the drop in Eledon Pharmaceuticals' long position.

The idea behind Dynavax Technologies and Eledon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.